Javaid, M.K. http://orcid.org/0000-0001-7985-0048
Harvey, N.C.
McCloskey, E.V.
Kanis, J.A.
Cooper, C.
Article History
Received: 28 May 2021
Accepted: 21 December 2021
First Online: 14 March 2022
Declarations
:
: J.A.K., N.C.H. and E.V.M. are responsible for the creation and maintenance of FRAX but derive no financial benefit. E.V.M. has received consultancy/lecture fees/grant funding/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, Sanofi Aventis, UCB, Viiv, Warner Chilcott and I3 Innovus. C.C. reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. N.C.H. has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Radius Health, Servier, Shire, UCB, Consilient Healthcare and Internis Pharma. M.K.J. reports personal fees from UCB, Amgen and Kyowa Kirin. J.A.K. reports no additional competing interests.
Free to read: This content has been made available to all.